Anandamide (AEA)
Endocannabinoid
Anandamide is an endogenous N-acylethanolamine signaling lipid. It is not an approved supplement, and exogenous products lack established identity, route, dosing, and safety.
Pharmacokinetic model
A route-level PK model for anandamide (aea) is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Endocannabinoid
- Suggested cadence
- once daily
Research behind this entry
-
Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation
Locally administered anandamide dilated human skin microvasculature but did not support a role as a circulating forearm vasoactive hormone. This local pharmacology study did not provide systemic PK.
1 published study referenced in the app, each with a plain-language summary.